Page last updated: 2024-09-05

sb 203580 and ferric nitrilotriacetate

sb 203580 has been researched along with ferric nitrilotriacetate in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ferric nitrilotriacetate)
Trials
(ferric nitrilotriacetate)
Recent Studies (post-2010) (ferric nitrilotriacetate)
3,48941,137387057

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, Y; Nagasawa, T; Nishizawa, N; Oumi, S1

Other Studies

1 other study(ies) available for sb 203580 and ferric nitrilotriacetate

ArticleYear
Oxidative stress induces phosphoenolpyruvate carboxykinase expression in H4IIE cells.
    Bioscience, biotechnology, and biochemistry, 2006, Volume: 70, Issue:9

    Topics: Animals; Blotting, Northern; Buthionine Sulfoximine; Cell Line, Tumor; Ferric Compounds; Flow Cytometry; Gene Expression Regulation, Enzymologic; Glucose; Imidazoles; Liver; Male; MAP Kinase Signaling System; Nitrilotriacetic Acid; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peroxides; Phosphoenolpyruvate Carboxykinase (ATP); Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; RNA, Messenger; Thiobarbituric Acid Reactive Substances

2006